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Abstract 
Background: Indoor residual spraying (IRS) is known to reduce malaria transmission. In northern Uganda, a high 
endemic area, IRS has been implemented since 2006. Limited data however, exists on the effect of IRS on the malaria 
burden. This study sought to assess the effect of IRS on malaria morbidity in the high intensity area of northern 
Uganda. Retrospective routine data from ten health facilities in three districts which had received at least five rounds 
of IRS in northern Uganda was analysed. The primary outcome of interest was malaria morbidity, measured by the 
slide positivity rate (SPR). Descriptive statistics were used to describe the malaria morbidity stratified by age and sex. 
The average change in the malaria morbidity, measured by the SPR was assessed according to time, measured as 
calendar months. A fixed‑effects linear regression model was used which included a polynomial function of time and 
controlled for malaria seasonality and variations between districts/facilities.
Results: The total out‑patient department attendance in the ten health facilities for the study period was 2,779,246, 
of which 736,034 (26.5%) malaria cases were diagnosed with 374,826 (50.9%) cases of under 5 years and an overall 
SPR of 37.5%. The percentage point (p.p.) changes in SPR according to time measured as calendar months following 
IRS, revealed a decreasing trend in malaria morbidity in the first 3 months following each round of IRS. The highest 
percentage point decrease in the SPR was observed in the second month following IRS (9.5 p.p., CI −17.85 to −1.16, 
p = 0.026), among patients above 5 years. The SPR decline however waned by the fourth month following IRS, with 
an increase in the SPR of 8.4 p.p. at district level by the sixth month, p = 0.510.
Conclusion: The study results show that IRS was associated with a significant reduction in malaria morbidity in 
northern Uganda in the first 3 months following IRS. The malaria reduction however waned by the fourth month fol‑
lowing IRS.
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Background
Over the past decades, the beneficial effects of IRS in 
malaria prevention have been reported in both high and 
low malaria endemic areas [1–7]. IRS contributed to the 
elimination or dramatic reduction of malaria in various 
parts of Latin America, Asia, and Europe [8].
Uganda has some of the highest recorded malaria 
transmission rates in Africa with an average of 1500 
infectious bites per person per year in the high intensity 
areas and one of the world’s highest malaria incidences 
of 478 cases per 1000 persons per year [9, 10]. Malaria 
transmission in Uganda is perennial, with two peaks fol-
lowing the rainy seasons, April/May and September/
November. In northern Uganda, the rain season is from 
March/April to October. Malaria is a leading cause of 
morbidity and mortality with an estimated 8–13 million 
cases per year which account for 30–50% of outpatient 
visits, 15–35% of hospital admissions and 9–14% of inpa-
tients deaths, where nearly half of the deaths are in chil-
dren less than 5 years of age [11].
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The primary malaria control intervention strategies 
implemented in Uganda include diagnosis and case man-
agement with artemisinin-based combination therapy 
(ACT), integrated vector management (IVM) includ-
ing use of long-lasting insecticide-treated nets (LLINs), 
and intermittent preventive therapy in pregnancy. In 
2006, IRS supported by United States Agency for Inter-
national Development (USAID)/President’s Malaria Ini-
tiative (PMI) was added to the intervention strategies for 
malaria control initially focusing in malaria prone areas 
in the southwest and later concentrating on the highly 
endemic areas in northern Uganda. After achieving a sig-
nificant decline in malaria control, the USAID/PMI man-
date was to gradually phase out the spray programme and 
thereafter conduct continuous entomological monitoring 
in sentinel sites in the phased-out districts. The program-
matic benefits of successful IRS programmes in Africa 
have been documented in several studies [12–17]. In 
northern Uganda, selected districts received five rounds 
of IRS during the study period but limited data exists on 
the impact of IRS on malaria morbidity in this area.
Methods
Study setting
This study analysed data from ten health facilities located 
in Apac, Gulu and Kitgum districts in northern Uganda. 
Northern Uganda, a post-conflict area of over two dec-
ades, is characterized by several wetlands and local for-
est reserves making it highly endemic to malaria. Malaria 
transmission in northern Uganda is also perennial, with 
two peaks following the rainy seasons in April/May and 
September/November. The following health facilities 
were included in this study: Aduku Health Centre IV 
(HCIV) in Apac district; Kitgum Government Hospital 
(KGH), St. Joseph’s Hospital and Namokora HCIV in Kit-
gum district; and Lacor hospital, Gulu Independent Hos-
pital, Gulu Regional Referral Hospital (GRRH), Military 
Hospital, Lalogi HCIV and Awach HCIV in Gulu district.
Description of IRS activities
IRS was reintroduced in Uganda in 2006 after a long 
period of no IRS interventions since 1960. Initial IRS 
activities were conducted in epidemic prone districts in 
the south-western part of Uganda before shifting to the 
highly endemic regions of northern Uganda as stipulated 
in the WHO position statement on IRS [18]. Initial pilot 
spray rounds in northern Uganda used dichlorodiphe-
nyltrichloroethane (DDT). Consistent biannual spray-
ing in ten districts of northern Uganda commenced in 
November 2009, targeting over 2.7 million people with 
approximately 850,000 households. The study districts 
had received five spray rounds over the 5-year study 
period starting November 2009 up to the end of the study 
period, December 2011 (2007–2011). The study consid-
ered these spray rounds as rounds one to five. The spray 
rounds were conducted biannually at different times in 
the different districts starting with a pyrethroid insec-
ticide (alpha-cypermethrin) before shifting to a carba-
mate (bendiocarb) (see Additional file 1). The first spray 
round was conducted starting November 2009 with Kit-
gum district and ending in May 2010 with Gulu district 
using alpha-cypermethrin insecticide. The second to fifth 
spray rounds occurred at approximately 4 months’ inter-
vals starting June 2010 to December 2011 using bendio-
carb. On average, the percentage coverage of households 
sprayed and population protected in all the five rounds 
was 97%.
Data collection procedures
Uganda has an integrated Health Management Informa-
tion System (HMIS) which produces aggregated monthly 
routine reports on various health outcomes. Data is col-
lected by health personnel at facility level during routine 
patient care and aggregated on a monthly basis by the 
health facility records personnel. Aggregated reports 
are then compiled and submitted on a monthly basis to 
the district health office. Of the ten districts where IRS 
was implemented, the study team was only able to access 
data from three districts: Apac, Gulu and Kitgum. This 
study analysed HMIS data from ten health facilities in the 
three districts and used it to estimate the effect of IRS on 
malaria morbidity in these districts of northern Uganda. 
The ten facilities were selected based on a criterion which 
considered data availability and completeness. Data was 
considered available and complete if permission to use 
it was granted by district authorities and if the variables 
of interest had no missing values. Retrospective data of 
a 5-year period (2007–2011) covering five rounds of IRS 
were analysed. The malaria variables analysed by the 
study included: malaria diagnosis categorized by age and 
sex; and blood smear (BS) tests including total tests done 
and total positive tests, segregated by age. In addition, 
the study used the total OPD attendance categorized by 
age and sex to assess the malaria prevalence. Age was cat-
egorized as <5 years and >5 years. Malaria morbidity was 
measured by the SPR which was the primary outcome of 
interest.
Statistical analysis
The malaria morbidity as measured by the SPR was 
evaluated and the change in the SPR in association with 
time, expressed as calendar months following IRS, was 
assessed using a linear fixed effects regression model that 
included polynomials of time and controlled for malaria 
seasonality and variations in districts and facilities. Sta-
tistical analysis included 604 observations from the 
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ten health facilities with 60  months ranging from Janu-
ary 2007 to December 2011. The 60-month time period 
raged from 0 to 59 with January 2007 analysed as month 
zero and December 2011 analysed as month 59.
The primary outcome of interest was the SPR which 
was also analysed by age categories of less than 5  years 
(<5  years) and above 5  years (>5  years). The IRS expo-
sure variable included a 6  months’ period following 
each round of IRS with time expressed as months after 
IRS. The month of spraying was considered as a baseline 
month and was assigned a zero while the months fol-
lowing the baseline month were assigned numbers 1–6 
consecutively. A month was considered a spray month if 
spraying occurred for more than or equal to 15  days in 
that month. The highest span between the spray rounds 
was a 6-month period.
Analyses were performed both at district and facil-
ity level using two linear fixed effects regression mod-
els regressed on the SPR as the outcome variable. Fixed 
effects regression deals with the lack of independence 
induced by the repeated-measures nature of the data 
[19]. The calendar time variable was included in the 
model as a 5th-degree polynomial to control for non-
linear malaria seasonality trends. Furthermore, dummy 
variables for facility and district were also generated and 
included in the model to control for any possible back-
ground differences between facility catchment areas. For 
modelling purposes, to avoid giving excessive weight to 
facilities performing a relatively low number of tests, 
observations were assigned a weight according to the 
total number of blood smear tests done at each facility. 
Two models were fitted of which one model included the 
months past variable (included as dummy variables), the 
5th degree polynomial function of calendar time and the 
categorical variables of facility weighted by total BS tests 
done while the other model replaced the facility variables 
with the district. The percentage change in the SPR in 
association to the time past following IRS expressed as 
calendar months was assessed, otherwise following the 
same procedure. A p value of <0.05 was considered sta-
tistically significant and confidence intervals (CI) were 
set at 95%. All statistical analysis was carried out using 
STATA version 12.
Results
The characteristics of the ten health facilities are pre-
sented in Table  1. The total recorded OPD attendance 
in all the ten facilities over the 5-year study period was 
2,779,246 of which 1,652,054 (59.4%) were female and 
876,584 (31.5%) were <5  years of age. Overall a total of 
736,034 (26.5%) malaria cases were diagnosed of which 
374,826 (50.9%) were <5 years of age. A total of 664,000 
blood slide tests were done of which 244,417 (37.5) were 
positive. Overall, the proportion of malaria cases among 
OPD attendees was highest in female 57%, as compared 
to male 43%, and was higher in patients less than 5 years 
of age 51%, as compared to patients above 5 years of age, 
49%.
Changes in the SPR as a function of time after IRS
Considering the baseline time, the month of spraying, 
in relation to the months following IRS, there was a sus-
tained decrease in the SPR adjusted for variations at both 
facility and district level in the first 3  months following 
IRS. In the second month following IRS, a statistically 
significant decrease in the SPR of 6.0 percentage point 
(p.p.) and 6.5 p.p. was observed adjusted for variations 
at both facility and district level (CI −11.73 to −0.36, 
p  =  0.037 and CI −12.56 to −0.41, p  =  0.037, respec-
tively). Similarly, a continuous decrease was observed 
when the SPR was analysed by age categories both for 
patients less than 5 years of age and those above 5 years 
(CI −17.85 to −1.16, p  =  0.026 and CI −8.03 to 5.55, 
p =  0.718), respectively in the second month following 
IRS. However, the decreasing trend in the SPR started to 
reverse to an increase in the fourth to sixth months fol-
lowing IRS. In the sixth month following IRS, an increase 
of 8.4 p.p. and 5.3 p.p. was observed after adjustment for 
variations at both facility and district level respectively 
(CI −16.66 to 33.39, p = 0.510 and CI −18.04 to 28.58, 
p =  0.655 respectively). Analysis of the SPR by age also 
revealed an increase among patients less than 5 years of 
age and among patients above 5 years of age.
The details of the regression results 6 months after IRS 
adjusted for variations at facility level including analysis 
by age categories are illustrated in Table 2. The regression 
results adjusted for variations at district level are given in 
Table 3, which shows 8.4 p.p. increase in the SPR by the 
sixth month following IRS.
SPR trends after IRS
The SPR had a declining trend for the first 3 months fol-
lowing IRS which however waned by the fourth month 
following IRS as illustrated in Fig. 1. A similar declining 
trend which waned off by the fourth month was observed 
when the SPR was analysed by age category. The SPR was 
higher among patients less than 5  years of age as com-
pared to those above 5 years of age as illustrated in Fig. 2.
The annual SPR at facility level confirms a decline 
in the SPR in the years following IRS, 2010 and 2011 at 
all the ten facilities. In Lacor hospital for example, the 
annual SPR declined to 6% in 2011 from 41% in 2009. 
The total annual SPR for the ten health facilities over the 
study period is highlighted in Table 4. The adjusted con-
fidence intervals of the percentage point changes in the 
SPR at facility level over time are in Table 5.
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There was a notable decline in the monthly SPR 
across the ten facilities in the months following IRS. The 
monthly trend in the SPR from five health facilities across 
the study period is illustrated in Fig.  3. The percentage 
point differences in the SPR between districts with Apac 
district as the reference district and the percentage point 
differences in the SPR between facilities with Aduku 
HCIV as the reference facility are highlighted in Table 6. 
Table 1 Characteristics of the study population
OPD Out patients Department, BS blood slide, SPR slide positivity rate, HCIV Health Centre IV, GRRH Gulu Regional Referral Hospital, KGH Kitgum Government Hospital, 
SJH St. Joseph’ Hospital
District Facility Total OPD 
attendance
















Apac Aduku HCIV 150,090 90,625 (60.4) 51,249 (34.1) 45,120 (30.1) 25,208 (55.9) 58,884 23,362 (39.7)
Gulu Lacor Hospital 845,254 515,362 (61.0) 286,836 (33.9) 164,117 (19.4) 110,229 (67.2) 289,288 95,207 (32.9)
Military Hospital 54,399 22,343 (41.1) 13,330 (24.5) 18,331 (33.7) 5000 (27.3) 11,347 2981 (26.3)
GRRH 246,216 152,137 (61.8) 48,654 (19.8) 73,620 (29.9) 25,406 (34.5) 24,698 8539 (34.6)
Lalogi HCIV 142,211 85,412 (60.1) 52,419 (36.9) 36,032 (25.3) 18,784 (52.1) 26,092 15,299 (58.6)
Gulu Independ‑
ent
44,130 23,557 (53.4) 6382 (14.5) 4969 (11.3) 1574 (31.7) 16,802 2640 (15.7)
Awach HCIV 86,815 56,469 (65.0) 27,615 (31.8) 35,123 (40.5) 15,468 (44.0) 7462 2264 (30.3)
Kitgum KGH 387,499 226,537 (58.5) 114,172 (29.5) 126,286 (32.6) 58,166 (46.1) 91,442 38,229 (41.8)
SJH 187,745 105,085 (56.0) 71,644 (38.2) 65,346 (34.8) 37,771 (57.8) 75,915 30,097 (39.6)
Namokora HCIV 173,438 93,578 (54.0) 58,417 (33.7) 45,483 (26.2) 20,697 (45.5) 5857 2798 (47.8)
Total 2,779,246 1,652,054 (59.4%) 876,584 (31.5%) 736,034 (26.5%) 374,826 (50.9%) 664,000 244,417 (37.5)
Table 2 Regression results adjusted for variations at facility level
p.p change percentage point change
Timing in relation to IRS p.p. change p value 95% confidence interval
Lower boundary Upper boundary
Percentage change in total SPR
 1 month after IRS −3.45 0.208 −8.86 1.95
 2 month after IRS −6.04 0.037 −11.73 −0.36
 3 month after IRS −6.53 0.040 −12.74 −0.31
 4 month after IRS −0.17 0.958 −6.53 6.19
 5 month after IRS −2.74 0.461 −10.05 4.58
 6 month after IRS 5.27 0.655 −18.04 28.58
Percentage change in SPR <5 years
 1 month after IRS −2.19 0.503 −8.64 4.27
 2 month after IRS −1.24 0.718 −8.03 5.55
 3 month after IRS −3.36 0.372 −10.77 4.06
 4 month after IRS 2.78 0.470 −4.80 10.35
 5 month after IRS −1.34 0.764 −10.13 7.45
 6 month after IRS 0.76 0.960 −29.37 30.89
Percentage change in SPR >5 years
 1 month after IRS −4.03 0.317 −11.95 3.90
 2 month after IRS −9.50 0.026 −17.85 −1.17
 3 month after IRS −8.18 0.079 −17.31 0.95
 4 month after IRS 0.73 0.876 −8.58 10.04
 5 month after IRS −3.40 0.533 −14.16 7.36
 6 month after IRS 7.95 0.647 −26.25 42.14
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The monthly SPR percentage points for Aduku HCIV, 
Lacor hospital, St. Joseph’s Hospital across the 60 months 
of the study period is also given on Fig. 4. The trend in the 
SPR percentage points at district level across the study 
period is given on Fig. 5. Both figures illustrate a declin-
ing trend in the SPR percentage points in the months fol-
lowing IRS.
Discussion
In this study, IRS was associated with a significant 
decrease ranging from 2.2 to 9 p.p. in malaria morbidity 
as measured by the SPR in northern Uganda following 
five rounds of spray with alpha-cypermethrin and ben-
diocarb. The malaria morbidity decrease was more pro-
nounced in the second month after IRS though the effect 
waned by the fourth to sixth month after IRS.
IRS, mainly with DDT, was the principal method by 
which malaria was eradicated or greatly reduced in many 
countries in the world between the 1940s and 1960s [8]. 
Reduction in malaria morbidity following IRS has been 
reported in similar studies conducted in various parts of 
Africa. A recent study on the effect of IRS on malaria and 
anaemia in northern Uganda associated IRS to a reduc-
tion in the malaria burden in high transmission settings. 
The study revealed parasitaemia prevalence among chil-
dren <5  years of age was lower in the two IRS districts 
(Apac and Pader) when compared with the non-IRS dis-
trict (Lira): 37.0% and 16.7 versus 49.8%, p < 0.001. Anae-
mia prevalence was also significantly lower in the two IRS 
districts: 38.8% and 36.8 versus 53.0%, p < 0.001. [20]. The 
results obtained in this study similarly show a decrease 
in malaria morbidity as measured by the SPR following 
IRS. In this study, IRS was associated with a 3.5 p.p. to 7.1 
p.p. decrease in the SPR in the first 3 months following 
IRS. The decrease ranging from 2.2 p.p. to 9 p.p. was also 
observed in the SPR when analysed by age category.
Another retrospective descriptive study to analyse 
the changes in the malaria morbidity and mortality and 
Table 3 Regression results showing percentage point change in total SPR adjusted for variations at district level
Two linear fixed effects regression models were regressed on the SPR as the outcome variable both at district and hospital level. The models are shown below
Hospital model SPR = β0 + β1 (time) + β2 (months past after spraying) + β3 (Hospital)
District model SPR = β0 + β1 (time) + β2 (months past after spraying) + β3 (District)
The regression results adjusted for variations at district level and the adjusted confidence intervals of the percentage changes in the SPR 6 months after IRS reveal 
the same results with a decrease in the SPR 1–3 months after IRS which wanes out in the fourth month following IRS. The same results are obtained when the SPR is 
analysed by age category as shown in Table 6. The SPR increases by the sixth month when compared to the spray month, the reference month = zero
Timing in relation to IRS Percentage point change p value 95% confidence interval
Lower boundary Upper boundary
1 month after IRS −4.18 0.157 −9.98 1.63
2 month after IRS −6.48 0.037 −12.55 −0.41
3 month after IRS −7.11 0.038 −13.80 −0.41
4 month after IRS −0.39 0.912 −7.27 6.50
5 month after IRS −2.97 0.459 −10.87 4.93
6 month after IRS 8.37 0.510 −16.66 33.39
Fig. 1 Trend of changes in the SPR in the months following IRS
Fig. 2 Change in the SPR over time by age category
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assess whether IRS had an impact on the malaria trends, 
conducted in Mpumalanga Province, South Africa, 
revealed a significant decrease in the incidence of malaria 
following IRS from 385 in 2001 to 2002 to 50 cases per 
100,000 population in 2008 to 2009 (p  <  0.005) [21]. 
Similarly, in this study, a decreasing trend in malaria 
morbidity as measured by the SPR was observed in the 
first 3  months following IRS. In this study however, the 
decline waned in the fourth to sixth month following IRS.
A similar before and after IRS study conducted to 
assess the impact of IRS on malaria morbidity in western 
Uganda, Kabale district in 2009 found that there was a 
large decrease in the SPR in the first 4 months after IRS 
both for patients <5 (47 versus 14%, p < 0.001) and >5 (26 
versus 9%, p < 0.001) years of age, but this effect waned 
over the subsequent 12  months [22]. Likewise, in this 
study, there was a significant decrease in the SPR both 
among patients <5 and those >5 in the first 3  months 
after IRS. However, this effect waned over the subse-
quent 3 months and an increase in the SPR started to be 
observed up to the sixth month after IRS.
Different risk factors for malaria transmission in 
Africa have been identified by various studies includ-
ing environmental factors such as altitude, temperature 
and climate; biological factors like the anopheles vector 
density; and human related factors and activities such as 
socio-economic status, health access, migration, gender, 
age, availability of control activities like IRS and LLITN, 
housing structure and land use [23–25] This study did 
not assess all of these factors; however, it is in agreement 
with other studies that showed that females and chil-
dren are the most vulnerable to the risk of malaria [26]. 
Generally, the highest malaria prevalence occurs in chil-
dren and females and the positive malaria diagnosis rate 
decreases with age. In this study, the malaria prevalence 
among OPD attendees was highest in female as com-
pared to male and was higher in patients less than 5 years 
of age as compared to patients older than 5 years of age.
A study conducted in a high-transmission-intensity 
area of Northern Uganda that assessed the association 
between IRS and malaria morbidity, revealed a much 
greater decrease in the odds of malaria in patients less 
than 5  years of age following three rounds of IRS with 
bendiocarb (ORs 0.34, 0.16, 0.17 respectively, p  <  0.001 
for all comparisons) [27]. In this study however, the pro-
tection by IRS was more pronounced in patients greater 
than 5  years of age, up to 9 p.p. decrease. However, a 
notable percentage point decrease of 3 p.p. was observed 
in patients less than 5  years of age following IRS. Evi-
dence from studies is suggestive of an age-acquired 
malaria immunity which makes younger patients more 
vulnerable to the disease [28]. Younger patients are there-
fore more dependent on malaria control interventions 
like IRS to prevent malaria transmission. The results of 
this study provide further evidence of the effectiveness 
of IRS in providing protection from malaria transmission 
in both age categories. As suggested by other studies, 
Table 4 Annual SPR at facility level across the study period
KGH Kitgum Government Hospital, GRRH Gulu Regional Referral Hospital
Hospital SPR 2007 SPR 2008 SPR 2009 SPR 2010 SPR 2011
Aduku 62.60 35.29 43.96 41.65 22.32
St. Joseph’s 42.87 44.34 56.37 33.92 6.74
KGH 48.69 43.19 43.59 41.55 20.16
Lacor 34.29 26.40 41.15 36.32 6.06
Military 39.22 20.12 31.00 24.48 16.48
Namokora 
HCIV
32.59 68.46 72.32 42.87 23.58
Gulu Inde‑
pendent
11.71 10.47 34.63 20.48 6.98
Lalogi HCIV 65.36 57.47 67.43 52.72 31.05
Awach HCIV 21.92 25.64 46.02 33.56 6.79
GRRH 26.91 30.43 39.93 35.19 21.70
Table 5 Adjusted confidence intervals of  the percentage 
point changes in the SPR at facility level
xb linear prediction, lb 95% confidence interval, lower boundary, ub 95% 
confidence interval, upper boundary
Months past after IRS xb lb ub
Overall SPR
  0 27.61 23.20 32.02
  1 24.16 20.00 28.31
  2 21.57 17.18 25.95
  3 21.08 15.89 26.28
  4 27.44 21.99 32.88
  5 24.87 18.38 31.37
  6 32.88 10.00 55.76
SPR <5 years
  0 29.97 24.70 35.25
  1 27.79 22.81 32.76
  2 28.73 23.47 33.99
  3 26.62 20.41 32.82
  4 32.75 26.26 39.24
  5 28.64 20.78 36.50
  6 30.74 1.049 60.42
SPR >5 years
  0 26.53 20.05 33.00
  1 22.50 16.41 28.60
  2 17.02 10.57 23.48
  3 18.35 10.70 26.00
  4 27.26 19.30 35.23
  5 23.13 13.54 32.71
  6 34.47 0.92 68.02
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several years of IRS may be needed in very high transmis-
sion areas before a significant health impact on malaria 
morbidity can be achieved [29].
In Uganda, IRS is now recognized as one of the malaria 
control interventions in the country. IRS campaigns were 
started in Uganda in 2006 with support from USAID/
PMI. Since 2009, the IRS activities were concentrated in 
ten high transmission districts in northern Uganda cov-
ering over 2.7 million people and 850,000 households. 
However; in 2014, the spray programme was phased 
out from these districts and emphasis was diverted to 
another 14 districts in Northern and Eastern Uganda. 
Following this decision, an increase in malaria cases was 
reported in all the ten districts [30]. These resurgence of 
malaria outbreaks in the region clearly demonstrates the 
beneficial effect of IRS in these districts.
Fig. 3 Monthly trends in the SPR in five health facilities
Table 6 Percentage point change in  the SPR adjusted 
for variations at district and facility level following IRS
This table highlights the percentage point differences in the SPR between 
districts with Apac district as the reference district and the percentage point 
differences in the SPR between facilities with Aduku HCIV as the reference 
facility. In general, the percentage point changes in the SPR adjusted for 
variations at facility and district level show a declining trend as compared to the 
reference points





Percentage point change in the SPR at district level
 District
  Gulu −8.59 0.006 −14.62 −2.56
  Kitgum −4.42 0.083 −9.42 0.58
Percentage point change in the SPR at facility level
 Facility
  Awach HCIV −10.47 0.032 −20.00 −0.94
  GRRH −3.48 0.620 −17.35 10.38
  Gulu Inde‑
pendent
−22.02 0.000 −33.90 −10.13
  Kitgum 
Hospital
−0.88 0.734 −6.02 4.25
  Lacor −10.16 0.062 −20.83 0.51
  Lalogi HCIV 6.04 0.235 −3.97 16.05
  Military 
Hospital
−11.42 0.015 −20.53 −2.28
  Namokora 
HCIV
2.22 0.682 −8.48 12.93
  St. Joseph −9.35 0.001 −14.59 −4.11
Fig. 4 Monthly change in SPR for Aduku, Gulu regional referral and 
St. Joseph. There was a declining trend in the SPR in the months 
following IRS across the 60 months study period, which shows a 
declining trend in the SPR percentage points from three facilities; one 
from each district
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Withdrawal of IRS requires a robust transition strategy 
which includes the application of IVM principles includ-
ing use of LLINs; robust epidemiological and entomo-
logical monitoring, including setting up sentinel sites 
for malaria surveillance, thereby strengthening district 
capacity to diagnose malaria by laboratory and clinical 
diagnosis; and regular communication of entomological 
vector population data with relevant implementing part-
ners in order to promptly manage the clinical cases of 
malaria that may arise.
Study limitations
This study lacked a control group to better quantify the 
effect of IRS in comparison with non IRS districts, which 
prompts us to be cautious about making causal infer-
ences on the estimated effect of the IRS. However, the 
overall decline in SPR in the months following the spray-
ing as well as the subsequent waning of the effect, point 
to a causal relationship between both variables, as the 
study team is not aware of any other simultaneous phe-
nomenon or intervention that could explain this behav-
iour besides the mass distribution of LLITNs in the study 
area. The mass distribution of LLITNs could unlikely 
explain the findings as similar studies that conducted 
separate analyses for IRS and LLITNs showed that 
ITNs were not associated with a significant reduction 
in malaria prevalence while IRS provided a significant 
added benefit in malaria reduction even in settings were 
ITN ownership is high. Although natural seasonal varia-
tions in SPR do exist, this is unlikely to explain the find-
ings as the sprayings did not occur simultaneously in all 
districts and the inclusion of calendar time variable in the 
models controlled for the non-linear malaria seasonality 
trends. A larger sample size would have enabled an easier 
detection of significant differences in the changes in the 
SPR over time, although the study still was able to find 
a significant effect of IRS. Despite the study limitations, 
the results presented draw attention to the effect of IRS 
on malaria morbidity, suggesting the reduction of malaria 
morbidity and/or even elimination are possible following 
a sustained and well managed IRS programme.
Conclusion
The results of this study show that an effective IRS pro-
gramme was associated with a reduction in malaria 
morbidity. In this study, malaria morbidity in northern 
Uganda, as measured by the SPR, was reduced in the first 
3 months following IRS. The decreasing effect of the SPR 
however waned 4–6 months following IRS. Further stud-
ies are needed to expound the waning effect and to assess 
whether a maximum of 3  months’ interval in the spray 
rounds would retain a decreasing trend in the SPR. Fur-
thermore, studies to assess the efficacy of different classes 
of insecticides and possible insecticide resistance in the 
spray area should also be conducted.
This study recommends an up-scaling of a sustained 
and well-managed IRS programme across the nation with 
a special focus on malaria high transmission intensity 
areas. Furthermore, the study recommends an enforce-
ment of a robust transition strategy following IRS with-
drawal. Additionally, this study recommends conducting 
further studies to better quantify the impact of IRS with 
the use of a control group.
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